Moderna Inc MRNA
News
Moderna gets U.S. government funding for bird-flu vaccine development
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
Bird-flu testing, vaccines and treatments: 5 -2-
Bird-flu testing, vaccines and treatments: 5 things you need to know now
Moderna's RSV vaccine gets positive opinion from EU advisory panel
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
Vaccine makers' stocks fall as CDC advisers shift RSV-shot recommendations
Moderna's stock falls after data shows biotech's RSV vaccine trails rivals after 18 months
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
Worried you missed the Nvidia bandwagon? Here are some alternative stock picks.
Worried you missed the Nvidia bandwagon? Here -2-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Moderna's combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA